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Abstract 
 
The efficiency of somatic cell nuclear transfer has been improved slightly with the use of 
Demecolcine as a chemical enucleant.  While the reasons for this improved efficiency 
remain unclear, it has been hypothesized that the Demecolcine assisted enucleation 
procedure is less exigent to vital cell processes within the oocyte including the Anaphase-
Promoting Complex (APC) dependent ubiquitination of proteins.  In order to test the 
effect of Demecolcine on the APC, the spatial localizations of Apc11, the catalytic core 
of the complex, and Cdc20, a main activator of the complex, were studied in developing 
mouse oocytes.  In control oocytes, a high concentration of Apc11 protein was observed 
surrounding the meiotic spindle, but this perispindular localization was not observed in 
oocytes treated with Demecolcine.  Similarly, oocytes stained for Cdc20 also 
demonstrated cytoplasmic localization in control oocytes with a variation consistent with 
previous studies in total protein at different stages of development.  However, in oocytes 
treated with Demecolcine, this developmental variation was not observed.  These data 
suggest that since both Apc11 and Cdc20 localization are affected by an incubation in 
Demecolcine, the activity of the APC would also be affected.  In order to test this theory, 
Rec8, a meiotic specific member of the cohesion complex, was localized in developing 
mouse embryos.  Since the destruction of Rec8 is a downstream consequence of the 
ubiquitination pathway, Rec8 localization serves as an indirect indicator of APC activity.  
The data indicate Rec8 localization was only subtly influenced by Demecolcine, thus the 
magnitude of the drug’s effect APC activity remains unclear.  (249words) 
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Introduction 
The efficiency of Somatic Cell Nuclear Transfer (SCNT) or animal cloning is 
extremely low.  Typically, healthy progeny are produced from only 1-2% of 
reconstructed embryos (Kato et al., 1998).  This low efficiency may be due in part to the 
enucleation methods used in the cloning procedure.  In traditional SCNT, oocytes 
arrested at metaphase of meiosis II (MII) are stained with Hoechst 33342 and exposed to 
UV irradiation to cause the fluoresce of the chromatin.  Under constant UV exposure, the 
oocyte is punctured and its chromosomes are manually removed with a fine bore glass 
pipet creating an enucleated egg or cytoplast.  The cytoplast is then injected with DNA or  
fused to a somatic cell.  The reconstructed embryo is then stimulated to continue 
development into an embryo and beyond.  This process is technically difficult, requiring 
expensive equipment and significant micromanipulation training.  Additionally, not only 
is this a very labor intensive process, it is widely believed that, due to the invasiveness of 
this method, the egg may be irreversibly damaged beyond the point where healthy 
development can be sustained.   
There are two main observations in support of this notion.  Firstly, exposure to 
UV light has been shown to negatively affect oocyte competence in several species 
(Smith, 1993; Velilla et al., 2002) by disturbing membrane processes, intracellular 
elements, and mitrochondrial chromatin.  Secondly, the manual removal of the MII 
chromosomes is imprecise.  During this process, the meiotic spindle, the surrounding 
cytoplasm, and any other cellular components associated with the meiotic spindle like the 
anaphase-promoting complex (APC) are also removed from the egg.  Unfortunately, 
many of these cytoplasmic components are crucial to the developmental competence of 
the enucleated oocyte and their removal has been demonstrated to reduce the cytoplast’s 
ability to support later development.    
In order to increase the efficiency of SCNT, Baguisi and Overstrom (2000) 
reported the use of Demecolcine, a derivative of colchicine, to aid in the enucleation 
procedure.  The MII oocytes were incubated in Demecolcine to depolymerize the meiotic 
spindle and the oocytes subsequently activated.  It was observed that oocytes extruded the 
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chromatin in the second polar body with a high efficiency.  Using this method, it was 
suggested that the karyoplast could then be removed more easily.  Demecolcine-assisted 
enucleation has since been effective in several species including mice (Baguisi & 
Overstrom, 2000), sheep (Hou et al., 2006), and cows (Russel et al., 2005).   
The APC is a multimeric protein complex that ligates ubiquitin chains to several 
protein substrates; thereby marking them for destruction by the 26S proteasome 
(reviewed by Castro et al., 2005) and driving both the mitotic and meiotic cell through 
the cell cycle (reviewed by  Zachariae & Nasmyth, 1999 and many others).  S. cerevisiae 
mutants lacking various subunits of the APC have been shown to arrest in metaphase 
(Hartwell et al., 1970).  Additionally, the APC was required for the initiation of anaphase 
in C. elegans (Furuta et al., 2000), yeast (Salah & Nasmyth, 2000), and mouse (Terret et 
al., 2003).  Since unsuccessful cloning attempts often fail to initiate anaphase (Overstrom 
Laboratory unpublished results), it is believable that the APC is somehow affected by the 
enucleation procedure. Therefore, the purpose of this project was to determine the effects 
of Demecolcine-induced microtubule depolymerization on the spatial localization of the 
anaphase-promoting complex (APC) and other markers of APC activity. 
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Literature Review 
Animal Cloning Techniques 
 
Animal cloning or somatic cell nuclear transfer (SCNT) is the process by which 
an oocyte is enucleated, reconstructed with the DNA of another donor cell, and then 
stimulated to develop into a live organism.   The overall goal of this process is to produce 
offspring with specific genotypic qualities identical to that of donor cells from a founder 
animal.  SCNT has been successfully employed to produce a variety of organisms 
including sheep (Wilmut et al., 1997), cows (Kato et al., 1998), goats (Baguisi et al, 
1999; Lan et al., 2006) and several others.  However, nearly a decade after Wilmut et al. 
(1997) reported the birth of Dolly the sheep, the first live mammal cloned from an adult 
cell, the efficiency of this technique remains exceedingly low (2-5%) despite the variety 
of cloning methods employed (reviewed by Kato et al., 1999; Campbell et al., 2005).   
Creation of a Cytoplast 
There are three major steps in the production of a live mammalian clone: the 
generation of a cytoplast, the reconstruction of an embryo, and activation/ subsequent 
development of the clone.  The first step is the generation of a cytoplast capable of 
epigenetically reprogramming a somatic cell genome to support the full development of a 
cloned offspring.  To create a cytoplast, the nucleus of an oocyte is removed.  While 
oocytes can be gathered from slaughterhouses and matured in vitro (reviewed by 
Campbell et al., 2005), such a procedure often leads to cytoplasts of reduced 
developmental competence (Wells et al., 1997).  Therefore, mature oocytes are most 
often harvested from hormonally primed individuals at the stage where the cell is 
naturally arrested at metaphase of the second meiotic division (MII).  At MII, the DNA is 
tightly compacted along the metaphase plate at the center of the meiotic spindle, a 
microtubule complex that assists in the proper alignment and segregation of sister 
chromatids.  To remove the DNA from the cell, the egg is punctured with a finely pulled 
needle and the entire meiotic spindle is aspirated along with variable amounts of the 
surrounding cytoplasm.  Because the spindle complex is difficult to visualize under 
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standard bright field conditions, the DNA is typically localized by staining with a 
Hoechst dye and visualized by fluorescence microscopy.  Unfortunately, UV exposure 
can damage mitochondria and several other membrane processes (Smith, 1993; Velilla et 
al., 2002).  Additional complexities of this technique include the requirement of 
specialized technical training on relatively expensive equipment (i.e. micromanipulator, 
inverted fluorescence microscope).   
One alternative to the micromanipulation procedure is a technique developed by 
Vajita et al. (2001) called “handmade” cloning.  In this system, the need for 
micromanipulators has been circumvented by the preparation and fusing of two half 
cytoplasts.  Two oocytes were bisected and the portions with the nuclei were discarded.  
The remaining two halves were then fused with nuclei from a donor cell, creating a fully 
reconstructed embryo.  While this is a simple alternative to conventional cloning, the low 
success rates still prevent this method from becoming economically viable.   
Alternatively, Baguisi and Overstrom (2000) reported a method by which 
Demecolcine, a microtubule destabilizing agent, can aid in the enucleation process.  MII 
stage eggs were activated and subsequently incubated in various agents affecting 
microtubule confirmation.  54% of eggs incubated in Demecolcine demonstrated induced 
enucleation, whereby the nuclear chromatin was extruded in the second meiotic polar 
body.  Baguisi and Overstrom (2000) were then able to produce live healthy offspring 
from the generated cytoplasts, demonstrating the potential effectiveness of the chemically 
assisted enucleation approach.      
Embryo Reconstruction 
The second step in the creation of an animal clone is the reconstruction of an 
embryo.  To reconstruct an embryo, the DNA from the nucleus of a donor cell 
(karyoplast) must be stably incorporated within the new generated cytoplast.  This is 
accomplished in one of several ways. The most common method is by electrofusion 
(reviewed by Ramos & Teissie, 2000).  In this process, an electric field is applied to both 
the cytoplast and donor cell.  Under specific electric conditions, the cell membrane of 
both “cells” will destabilize and, when brought into close contact with one another, the 
two membranes will merge.   Thus, a newly reconstructed embryo is created with the 
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genetic material of the donor cell and the cytoplasm of an enucleated oocyte capable of 
epigenetic reprogramming.   
In some species (like mice) where electrofusion is less effective, embryo 
reconstruction is accomplished by piezo injection (Chen et al., 2004). According to 
EXFO, the maker of the PiezoDrill, high-frequency impulses are produced by a motor 
within the drill that travel longitudinally along an injection pipet.  These impulses allow a 
glass pipet to pass though the zona pellucida and into the cyplasm of the oocyte without 
destroying the cell membrane.  The donor cell nucleus can then be injected directly into 
the cytoplast creating a reconstructed embryo.   
 Another alternative to electrofusion is to use a non-touch laser to open a hole in 
the zona.  The laser softens the membrane of the cell allowing for a blunt pipet (instead of 
a sharpened pipet) to be used for removal/ injection of chromatin.  While no live 
offspring have yet been reported using this technology, advantages (as reported by 
Hamilton Thorne Biosciences- the maker of the XYClone Laser) include an increased 
speed and efficiency over traditional microinjectors and a resultant reduction in the 
trauma of the oocytes (Chen et al., 2004; reviewed by Campbell et al., 2005). 
Activation and Development 
Following the reconstruction of the embryo, it is necessary to stimulate the egg to 
continue to grow and divide.  Naturally, developing oocytes arrest at MII where they 
await an oscillating calcium signal caused by an invading sperm (reviewed by Jones, 
2005).  The calcium signal activates calmodulin-dependent protein kinase II which then 
activates the anaphase promoting complex to initiate the destruction of cyclin B, the 
regulatory element of Maturation Promoting Factor (MPF), and securin, an enzyme that 
prevents the premature cleavage of cohesion complexes, thus, allowing the cell to 
progress from meiosis into mitosis (Jones, 2005).  This calcium signal can be mimicked 
artificially in many ways both chemically and electrically.  In mice, the standard 
parthenogenetic activation stimulus is SrCl2.  The strontium causes repetitive calcium 
transients to occur as organelle stores are released into the cytoplasm (Ibanez et al., 
2005).  Ethanol has also been shown to activate mouse oocytes by causing the formation 
of inositol 1,4,5-triphosphate at the membrane and a concomitant influx of extra-cellular 
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calcium (Ibanez et al., 2005).  Ionomycin, a calcium ionophore, has also often been used 
in mice, sheep, and cows.  Other reported parthenogenetic activation protocols include 
electroporation in media containing CaCl2 or a microinjection of CaCl2 into the 
cytoplasm (Machaty et al., 1996). 
 Following activation and cleavage, embryos are transferred into surrogate mothers 
for development to term.  While in some species, embryos can be immediately 
transferred into the host carrier, in most cases the embryos are developed in vitro to 
blastocyst stage prior to transfer.  This allows for the morphologic selection of embryos 
before transplantation (Campbell et al., 2005).  
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Anaphase Promoting Complex Background 
APC in somatic cells 
The Anaphase Promoting Complex (APC) is a multi-subunit protein that is crucial 
in the regulation of the cell cycle (Peters, 2002) with subunit APC11 serving as the 
catalytic core (reviewed by Castro et al., 2005).  In somatic cells, the main function of the 
APC is the ubiquitination of cyclins (specifically cyclin B) and securin.  Ubiquitin is a 
76aa molecule that acts as a signal that causes the target protein to be transported to a 
proteasome for degradation (Chau et al., 1989).  The destruction of cyclin B leads to the 
inactivation of Cdk1, a cyclin-dependent kinase that initiates M phase in eukaryotic cells 
(Zachariae & Nasmyth, 1999).  The inactivation of Cdk1 during anaphase and telophase 
is necessary for both the formation of prereplicative complexes and chromosome 
decondensation (Peters, 2002).  Hence, the APC indirectly leads to the inactivation of 
Cdk1 by marking cyclin B for destruction.   
 The other main function of the APC in somatic cells is to label and destroy 
securin.  Since securin binds and inhibits separase, its destruction indirectly activates the 
protease.  Separase works to cleave SCC1 (Rec8 in meiotic cells), a subunit of the 
cohesion processes that hold sister chromatids together from metaphase until anaphase 
(Peters, 2002).  Additionally, since Cdk1 initiatorily phosphorylates separase, the APC 
affects separase activity in two ways; by the reduction of cyclin B concentrations and the 
destruction of securin. (See Figure 1). 
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Figure 1 - Initiation of Anaphase by the APC (Peters, 2002) 
 
 The APC is activated at different parts of the cell cycle by the binding of Cdc20 
and Cdh1.  Early in mitosis when cdk activity is high, the APC binds Cdc20 and actively 
binds proteins with a destruction box (D-box), the aa sequence R-x-x-L-x-x-x-x-N/D/E 
common to all the substrates of APC
cdc20
 (Harper et al., 2002).  APC
cdc20 
degrades A-type 
cyclins during prometaphase and B type cyclins and securins during the beginning of 
metaphase (Peters, 2002). Alternatively, since Cdh1 is inhibited by cdk activity, the APC 
binds Cdh1 during G1, where cdk activity is low (see Figure 2). Similar to APC
cdc20
, 
APC
chd1 
also binds proteins with a specific sequence.  That sequence, known as a KEN 
box (K-E-N-x-x-x-D/N) is common to all substrates of APC
chd1
 including Cdc20 (Peters, 
2002).  Accordingly, since APC
chd1 
is responsible for the destruction of Cdc20, it helps 
regulate the activity timing of APC
cdc20
 (Harper et al., 2002).  Since APC
cdc20
 and 
APC
cdh1
 have different substrates, the APC has the ability to remain active throughout the 
changing conditions of the cell cycle.  
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Figure 2 - APC activity (Zacharaie et al., 1999) 
APC in M2 eggs  
 In normal vertebrate egg development, an egg will proceed through all of the 
steps of meiosis until it reaches a final step in which the cell can no longer advance 
without an external stimulus.  This pause in development is known as the metaphase II 
(M2) arrest.  This arrest is partially caused by cytostatic factor (CSF) which inhibits the 
APC from degrading cyclin B.  By maintaining high cyclin B-Cdc2 levels, the cells will 
remain at this arrest until fertilization. Upon fertilization, a series of Ca
2+
 signals initiate a 
cascade that ends in the destruction of cyclin B and the next cellular division (Nixon et 
al., 2002).  Experiments with cyclin B mutants without the D-box domain have shown 
that, if cyclin B is not degraded, no pronuclei will form and the cell will not exit meiosis 
after fertilization (Magdwick et al., 2004).   
Hysop et al. (2004) propose a model for mammalian eggs in which the Ca
2+
 
signal affects the activity of the APC during a metaphase arrest and not the 26S 
proteasome as earlier characterized in lower organisms (Chiba et al., 1999).  Hysop et al. 
propose that the Ca
2+
 signal stimulates the loss of an APC inhibitor.  One potential 
inhibitor Hysop et al. mentioned was Emi1 because of a potential phosphorylation site by 
CaMKII, the known Ca
2+
 transducer at fertilization (Markoulaki, 2003).  However, 
Ohsumi et al. (2004) has reported that the M-phase arrest stimulated by Emi1 is separate 
from a CSF arrest in frogs (Xenopus).  If Emi1 is not the APC inhibitor, it is also possible 
that CSF may be a novel Ca
2+
-dependent inhibitor of the APC (Hysop et al., 2004).   
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During metaphase, securin maintains the inactivity of separase, an anaphase specific 
protease, until all the chromosomes are properly aligned or the initiation of anaphase 
(Wirth et al., 2006).  At the onset of anaphase, the destruction of securin (regulated by 
APC ubiquitination) allows separase to cleave the SCC1 subunit (Rec8 in meiotic cells) 
of cohesion, thus allowing sister chromatids to separate. 
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APC Subunits  
Apc11/Apc2 as the catalytic core 
The cullin-RING subunits Apc2 and Apc11 of the APC are believed to be the 
catalytic core of the complex (Gmachl et al., 2000; Leverson et al,. 2000; Tang et al. 
2001).  Although Apc11 is among the smallest of the APC subunits discovered (Passmore 
et al., 2005) Gmachl et al., (2000) have shown that recombinant human Apc11 and only 
Apc11 (not any of the other known subunits of the APC) is sufficient for the synthesis of 
multiubiquitin chains in vitro in the presence of an E1 enzyme, Ubc4 and an ATP 
regenerating system.  This synthesis occurred in both the presence and absence of 
substrates.  However, these chains were non-specific as a D-box mutant of securin was 
ubiquitinated as well as the wild type securin.  Additionally, Tang et al. (2001) coinfected 
Hi5 insect cells with viruses containing 10 APC subunits.  Combined, the multiple 
baculoviruses conveyed ubiquitin ligase activity. This activity was lost if only Apc2 or 
Apc11 were removed.  Furthermore, Tang et al (2001) showed that the Apc2/11 complex 
is sufficient for the ubiquitination of securin with UbH10 as the E2 enzyme.  Tang et al. 
(2001) then showed that while Ubc4 can interact directly with the RING of Apc11, 
UbH10 binds Apc2 strongly and Apc11 weakly. 
 
Structure of Apc11 RING finger 
 The E3 ubiquitin ligase activity of the APC is conveyed by two Zn
2+
 ions binding 
within the RING domain of Apc11 and perhaps partially a third Zn
2+
 outside of the RING 
motif (Tang et al., 2001).  When coordinating with these Zn
2+
 ions, a stable tertiary 
RING structure is formed.  This RING structure is necessary for the ubiquitination of 
APC substrates as mutants with disrupted ring structures show significantly reduced to no 
ubiquitin ligase capability (reviewed by Peters, 2002). Although Tang et al., (2001) 
demonstrated that high levels of Zn
2+
 alone can catalyze minimal levels of a 
ubiquitination reaction in the presence of an E2, it is not yet known whether the RING 
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structure of the APC directly catalyzes the ligase reaction through the Zn ions or whether 
it allows for a stable proximity reaction to occur (Passmore & Barford, 2004).   
 
Structure of Apc2 
 As the second largest protein of the APC (Jorgensen et al., 2001), Apc2 is a 
protein with a cullin C-terminal homology region that binds strongly to Apc11 (Tang et 
al., 2001). All cullin proteins form a rigid scaffolding-like structure by binding the RING 
with their C-terminal domain while the N-terminal region is thought to actively recruit 
the E2 enzymes (reviewed by Petroski & Deshaies, 2005).  The structure of Apc2 has 
been inferred from its homology to Cul1, another cullin protein in the SCF E3 ligase 
(Zheng et al., 2002).  This inference is further supported by the fact that, while the 
sequence homology of the two proteins is mainly restricted to the C-terminal cullin 
domain (Passmore, 2004), a crystal structure of the C-terminal 78 aa (well outside of the 
cullin region) forms a hinged-helix that can be superimposed over the same Cul1 region 
(Zheng et al., 2002).  Along the C-terminus, Cul1 forms a V-shaped groove that binds 
Rbx1, a RING finger protein comparable to Apc11 (Zheng et al., 2002). 
Along its N-terminus, Cul1 contains several helical repeats that are arranged to allow for 
the binding of Skp1, a linker protein that binds substrates of the SCF containing an F-
box.  
 
Apc10 (Doc1) 
 Apc10 is required for E3 ligase activity on certain substrates and plays a specific 
role in substrate recognition (Passmore et al., 2003).  Apc10 interacts directly with 
Apc11, the catalytic core of the APC (Tang et al., 2001).  Mutants of both fission and 
budding yeast lacking Apc10 show an arrest at metaphase and the accumulation of 
mitotic cyclins (Kominami et al., 1998). Apc10 is the first member described in the Doc 
homology family, a group of proteins that have been detected in other E3 ligases 
unrelated to the APC (reviewed by Passmore, 2004).  Although its specific role is still 
undefined, Passmore et al. (2003) proposed that, since Apc10 mutants have a diminished 
ability to bind substrates, it functions as a regulator of substrate recognition.  An 
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additional report by Carroll & Morgon (2002) shows that Apc10 increases processivity, 
the addition of multiple ubiquitin molecules in a single binding event, by reducing 
substrate disassociation.  
 
Apc1 (Tsg24) 
 Apc1 is the largest subunit of the APC (reviewed by Castro et al., 2005) and 
transiently localizes to the centromeres of mammalian chromosomes (Jorgenson et al., 
1998) during mitosis in CHO cells and throughout the cell cycle in murine cells. Its 
homologues include BimE from Aspergillus nidulans and Cut4 from 
Schizosaccharomyces pombe (reviewed by Castro et al., 2005).  The predicted 3D 
structure contains Rpn1 and Rpn2, repetitive motifs that form a horseshoe-like structure 
(Jorgensen et al., 2001).  While the exact function of this repetitive sequence is unknown, 
it has been predicted that this horseshoe might play a role in binding unfolded proteins or 
as a scaffold for the rest of the APC (Lupas et al., 1997).   
 
Tetratricopeptide TPR repeats (Apc3, Apc6, Apc7, Apc8) 
 The TPR sequence motif is found in proteins with various biochemical activities 
and is thought to mediate protein-protein interactions (Castro et al., 2005).  TPR 
sequences arrange themselves into anti-parallel -helices that combine to form a right 
handed super helix (Das et al., 1988).  With specific aa residues on the outside and an 
extended grove inside the superhelix, the structure of multiple TPR sequences allows for 
the assembly of mult-protein complexes and the binding of an -helix in the center.  
Specifically, Vodermaier et al. (2003) showed that Apc3 and Apc7 bind to the c-terminal 
isoleucine-arginine (IR) region of both Cdc20 and Cdh1, key activators of the APC.  
Since all these TPR subunits are phosphorylated during mitosis and that phosphorylation 
is necessary for the activation of the APC, it is presumed that this phosphorylation event 
increases the binding ability of the APC to Cdc20 (Kraft et al., 2003; reviewed by Castro 
et al., 2005). Interestingly, Apc10 also contains an IR tail signifying that Apc10 
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association is also mediated by the TPR subunits. Apc7 has only been described in 
vertebrates.  
 
Apc4, Apc5  
 Less is known about these subunits.  It is hypothesized that these subunits along 
with Apc1 connect Apc2 and Apc11 to the TPR subunits (Vodermaier et al., 2003).   
 
Apc9, Cdc26 
Little is known about these two subunits other than the fact that they are required 
for overall structure of the APC.  Apc3 concentration is reduced in Apc9 and Cdc26 
mutants while Apc6 and Apc9 are reduced in Cdc26 mutants.  So far, Apc9 has only been 
described in yeast.   
 
Apc13(Swm1), Apc14, Apc14(Mnd2) 
Apc13, Apc14, and Apc15 are subunits that have only been described in yeast.  
While the biochemical function of these subunits is still unclear, it is hypothesized that 
they help maintain the structure of the APC.  Because the gene for Apc13 and Apc15 
were originally identified in meiotic screens (Ufano et al., 1999; Rabitsch et al., 2001), a 
role for Apc13 and Apc15 in meiosis has been predicted.     
Cdc20 (Fizzy) 
Cdc20 binds to the APC during mitosis.  Once bound, the APC becomes activated 
to ubiquitinate substrates containing a D-box, a short aa sequence that promotes APC 
recognition.  The degradation of these substrates including securin, Xkid, and several 
cyclins drives the cell through the mitotic cycle.   
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APC localization and activity  
 
Previously, mitotic APC localization has been observed in vitro (Tugendreich et 
al., 1995; Kraft et al., 2003; Acquiviva et al., 2004).  The staining of apc6 and apc3 
appears primarily on the centrosome at all cell cycle stages and coupled with the spindle 
following nuclear envelope breakdown (Tugendreich et al., 1995).  During interphase, 
Apc3 staining localized mainly to the nucleus and bound to the kinetochores in prophase. 
At pro-metaphase, the staining appeared on the spindle (poles and fibers) and on the 
centromeres of chromatids that had not yet aligned on the metaphase plate (Acquiviva et 
al., 2004).   Acquiviva et al. (2004) went on to show that Apc3 localization could be 
eliminated in mutant cells without an active spindle checkpoint.   
 It is widely believed that Apc3 localization is necessary for the function of the 
APC (reviewed by Pines & Lindon, 2005).  One proposed mechanism of the RING E3 
ubiquitin ligases (including the APC) is that of a molecular scaffold.  As the E3 binds 
both the E2 enzyme (ubiquitin conjugating enzyme) and the substrate, it brings specific 
lysine residues on the substrate into close proximity with an activated ubiquitin molecule 
(reviewed by Passmore & Barford, 2004). Additionally, Clute & Pines (1999) 
demonstrated that cyclin-B1 degradation occurs at the same location as APC localization 
in HeLa cells.  
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Cytoskeleton Affecters 
 
The cytoskeleton is composed of three types of protein filaments: actin filaments, 
microtubules, and intermediate filaments (IFs).    
 
Intermediate Filaments 
Intermediate Filaments (Ifs) have a diameter of ~10nm with an amino-terminal 
head, a central rod domain, and an carboxy-terminal tail. These non-polarized filaments 
typically play structural or tension bearing roles in the cell. The 4 types of IFs are keratin 
filaments (acidic and basic), vimentin-related filaments, and neurofilaments. While most 
IFs form apolar tetramers of anti-parallel dimers, lamins combine to form the 2D lattice 
of the nuclear lamina.  These lamins are broken down by cell cycle kinases upon entry 
into M-phase (Lodish et al., 1999).   
 
Microfilaments 
 Microfilaments (actin filaments) are composed of actin monomers (G-actin) that 
bind ATP and link together in a head-to-tail manner to form long polarized filaments with 
a diameter typically between 5 and 9 nm (Lodish et al., 1999).  These long filaments (F-
actin) have a negative and a positive end.  At the positive end, monomer addition occurs 
quickly while very little polymerization occurs at the negative end.  Once the filament 
reaches a steady-state length, ADP-bound monomers will separate from the minus end at 
the same rate as ATP bound monomers are added to the positive end. This process is 
called treadmilling.     
There are several drugs and proteins that affect microfilament characteristics.  The 
Cytochalasins are a group of fungal molecules that bind to the positive end of F-actin and 
prevent further addition of G-actin.  However, depolyermization at the minus end can still 
occur, thus leading to the overall depolyermization of the filament (Fementek fact sheet 
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on Cytochalsin [http://cytochalasin.4mg.com/]). Since Cytochalsin D, produced by 
Zygosporium mansonii, has been known to affect only the microfilament system and not 
the glucose transport system, it has become widely used in cellular manipulation 
techniques.  The concentration required for half-maximal inhibition with Cytochalsin D is 
20
-8
 M (Brown & Spudich, 1979). Cytochalasin D is soluble in methanol, ethanol, and 
DMSO and requires -20
o
C for long-term storage.  While both Cytochalasin D and 
Cytochalasin B inhibit actin function, Cytochalasin D is about 10-fold more potent than 
Cytochalasin B (Brown and Spudich, Figures 1&2, 1979).  Other Cytochalasins include 
Cytochalasin A,B,C, and E.  Cytochalasin A, isolated from Drechslera dematoidea, acts 
as an inhibitor of glucose transport, actin polymerization, and microtubule formation. 
Cytochalasin B, also isolated from Drechslera dematoidea, inhibits microfilament 
formation at 1 microgram/ml but at higher concentrations (about 5 g/ml) it begins to 
inhibit glucose transport (Fementek fact sheet on Cytochalsin 
[http://cytochalasin.4mg.com/]).  Cytochalasin C, isolated from Meterrhizium anisopliae, 
acts as a potent inhibitor of actin filament and contractile microfilaments. Cytochalasin E, 
isolated from Aspergillus clavatus inhibits angiogenesis and tumor growth by inhibiting 
F-actin formation in blood platelets.  
Phallotoxins are members of group of bicyclic heptapeptides isolated from the 
mushroom Amanita phalloides (Cooper, 1987).  In particular, Phalloidin binds along the 
sides of the microfilaments and prevents actin filaments from depolymerizing, thereby 
lowering the G-actin concentration needed for F-actin to form (Cooper, 1987).  
Phalloidin, supplied as a dried residue, is best dissolved to a concentration of 0.1 mg/ml 
in methanol (Small et al., 1999).  Depending on its conjugation, it can be stored at -20°C 
for several months.  A ratio of one Phalloidin molecule to every 1.7 actin promoters has 
been shown to be adequate for maximal depolymerization protection, with a 
disassociation constant of 85nM (reviewed by Cooper, 1987).  Fluorescently tagged 
Phalloidin (AlexaFluor 488 Conjugate available online [http://www.cambrex.com/]) has 
also been used to label F-actin.  Using tagged Phalloidin in excess to the binding sites 
allows for a quantitative measurement of the total amount of F-actin in a cell (Cooper, 
1987).   
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Jasplakinolide ([http://www.emdbiosciences.com/]) isolated from the sea sponge 
Japis johstoni, induces actin polymerization in vitro and competitively inhibits Phalloidin 
binding (Bubb et al., 1994) with a disassociation constant of 15nM.  This drug can be 
purchased as a powder or in a 1mM solution of DMSO from EMD or Molecular Probes 
(Eugene,OR) and must be stored at -20
o
C to be stable for 3-4 months.  In their actin-
binding studies, Bubb et al. (2000) determined that Jasplakinolide not only has the ability 
to bind F-actin faster than they were able to mix their samples, but also reduce the critical 
concentration of actin in a dose response manner (6-fold decrease at 0.15uM 
Jasplakinolide and 20-fold decrease at 0.3uM Jasplakinolide). 
 
Dolastatin 11, isolated from the mollusk Dolabella auricularia, also helps to 
stabilize F-actin in vitro (Oda et al., 2003).  For research use, this protein must be isolated 
or synthesized in house (Bai et al., 2001). This protein binds actin at a different cite than 
Phalloidin and Jasplakinolide.  When comparing the effects of Dolastatin 11 with those
 
of 
Jasplakinolide, minor microfilament destabilization occurred with both drugs at 30 min,  
and extensive destabilization occurred by 60 min (Bai et al., 2001).  In a study comparing 
the effects of several drugs on f-actin in vitro, Bai et al (2001) observed clear stimulatory 
effects at 10uM with Dolastatin 11 and Jasplakinolide, and modest stimulation with 
Phalloidin. 
 
Gelsolin is a protein found in many eukaryotic organisms including plants, lower 
eukaryotes, and vertebrates (for review see McGough et al., 2003).   In the presence of 
calcium, Gelsolin can cut an actin filament and cap it on the plus (barbed) end, 
preventing the addition of G-actin.  This severing effect is inhibited by Phalloidin (Way 
et al., 1992).  Without the addition of G-actin to the plus end the minus end of the 
microfilament can slowly depolymerize.  Additionally, Gelsolin has the ability to 
nucleate G-actin and begin the process of polymerization into F-actin if the concentration 
of G-actin is above a critical concentration.  Either human or bovine lyophilized gelsolin 
([http://www.sigmaaldrich.com/]) should be stored at -20
o
C.  Once dissolved in water, 
the solution is stable at 4
o
C for 1 week.   
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By binding to the sides of F-actin, Cofilin family members, including actin 
depolyermization factor (ADF), can cause the actin filament to twist improperly, 
disrupting the Phalloidin binding site.  Often this twisting breaks the filament and 
prevents further lengthening (for review see Bamburg, 1999).  Below pH 7, Cofilin 
increased the unassembled actin pool while co-sedimenting with F-actin.  Depending on 
the pH, Cofilin can depolymerize filaments at different rates.  Although Cofilin has been 
shown to increase the growth rate at the plus end, it increases the off rate at the minus end 
much more significantly (10 fold vs. 20-40 fold).  The critical concentration of human 
Cofilin to increase the G-actin concentration has been shown to be <2uM (Hayden et al., 
1993).  Recombinant chicken Cofilin (purchased from [http://www.sigmaaldrich.com/]) 
can only be stored at 4
o
C for a few days but lyophilized Cofilin (before being dissolved in 
dH2O) can be stored at -20
o
C for 6 months.    
Microtubules 
Microtubules are long tube-like structures made up of repeating heteromers of 
alpha and beta tubulin.  The walls of these microtubules are ~5nm wide while the entire 
diameter of the structure is around 25nm wide (Lodish et al., 1999).  Like 
microfilaments, these structures are also polarized with a fast growing, positive end and a 
slower negative end.  Often the minus end is anchored to the centrosome in animal cells.  
Microtubules comprise the mitotic spindle which is well known for its appearance and 
disappearance during the cell cycle.  This polymerization/depolymerization cycle is 
closely related to beta tubulin’s ability to bind and utilize GTP.  As more GTP is 
converted to GDP, the bonds of polymerization grow weaker, so the microtubules either 
grow slowly at the positive end or quickly degrade (Johnson, 2003). Similar to 
microfilaments, microtublins have also been known to undergo treadmilling (Wilson et 
al., 1999). While modifications to microtubules like acetylation help stabilize the protein 
complex, the foremost regulators of microtubule stability are proteins called Microtubule-
Associated Proteins (MAPs) including MAP-1, MAP-2 and tau, which can either 
promote the degradation of tubulin complexes or help to maintain the polymerized state. 
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Colchicine, Demecolcine (Colcemid
TM
), and Nocadazole all prevent microtubule 
polymerization by binding to tubulin at the plus end and not permitting further addition of 
protofilaments (Wilson et al., 1999; [http://cellbio.utmb.edu/]).  
 
Colchicine, isolated from the saffron plant, Colchicum autumnale, is an alkaloid 
that has the ability to stabilize the plus ends of microtubules greatly reducing the 
percentage of catastrophic collapse (Wilson et al., 1999).  The binding event of 
Colchicine to tubulin is a two-step process.  First, a pre-equilibrium complex forms 
between the two proteins.  This step represents a reversible, low-affinity binding event.  
After this pre-complex forms, the proteins undergo a slow period of distinct 
conformational changes until they form the final TC complex.  In this form, the binding 
of Colchicine and tubulin is nearly irreversible.  Once bound to the end of microtubules, 
the TC complex inhibits growth of that microtubule. This does not mean, however, that 
the microtubule ends are no longer competent to grow, as TC complexes can still attach 
to the plus ends of the microtubule (Wilson et al., 1999). The effects of Colchicine can 
occur at low concentrations, with only 1-2 molecules of Colchicine per microtubule 
reducing the rate of tubulin addition by 50%.  Additionally, at concentrations of 0.1-1 
µg/ml, Colchicine can cause the mitotic arrest of dividing cells (Sigma product sheet 
available online [http://www.sigma.com/]).  Colchicine is soluble in water, chloroform, 
benzene and can be autoclaved in solution for sterilization.  It can be stored in the dark 
for up to 6 months. 
   
Demecolcine (Colcemid
TM
) is the methylated derivative of Colchicine that has 
been shown to arrest cells in metaphase (Sigma product sheet available online 
[http://www.sigma.com/]).  It produces this effect because it depolymerizes microtubules 
and inhibits microtubule formation, thus inactivating the spindle arresting chromosomes 
at the metaphase plate (Calibochem product sheet available online 
[http://www.emdbiosciences.com/].   Because the cell cycle will continue normally once 
Demecolcine is removed, Demecolcine is readily reversible.  It is soluble in ethanol, 
chloroform, and DMSO to 10mg/ml.  Demecolcine is stable as a powder at room 
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temperature for 3 years.  When reconstituted, Demecolcine should be stored frozen at -
20
o
C for 6 months.    
 
Nocodazole arrests mitotic cells at the G2/M transition by depolymerizing 
microtubules in interphase and mitotic cells which arrests the cells.  Although 
Nocodazole is a competitive inhibitor of the binding between Colchicine and tubulin 
(Jordon et al., 1998), unlike Colchicine, the effects of Nocodazole are rapidly reversible 
(Vasquez et al., 1997).  Nocodazole increases the GTPase activity of tubulin by nearly 
five-fold.  This heightened activity increases the concentration of tubulin dimers in 
solution and thereby increases the rate of addition of these tubulin dimers to the 
microtubule.  The nature of the adjacent nucleotide bound at next to the tubulin dimer 
then determines whether the microtubule continues to grow (more slowly then before), 
pauses, or collapses (Vasquez et al., 1997).  The solubility of Nocodazole is 10mg/ml in 
DMSO (Sigma product information sheet).  When stored at 2
o
C the powder is stable for 
two years. When reconstituted in media, Nocodazole is stable for 1 week.  Also, 
Nocodazole has been demonstrated to act much faster than other microtubule 
depolymerizing agents like Demecolcine. 
 
Isolated from the periwinkle plant Catharanthus roseus, Vinblastine is a  vica-
related drug that does not compete for the Colchicine site on tubulin (Jordon et al., 1998).  
Despite this fact, Vinblastine, at low concentrations (<uM), affects microtubule dynamics 
in a manner similar to Cholchicine.  At a concentration of only 1-2 Vinblastine molecules 
per microtubule, Vinblastine inhibits polymerization at the plus end by 50% (Wilson et 
al., 1999) without significantly depolymerizing the microtubule. Additionally, by binding 
tubulin, Vinblastine changes the confirmation of the tubulin molecule.  This 
conformational change causes an aggregation of tubulin that, like Colchicine, reduces the 
catastrophe frequency and increases the rescue frequency of the microtubule (Wilson et 
al. 1999).  At a higher concentration (>5uM), Vinblastine will depolymerize the 
microtubules by removing tubulin monomers from both the plus and minus ends.  At an 
even higher concentration (>100uM), paracrystalline arrays of bound drug and tubulin 
form both in vitro and in vivo.  Vinblastine Sulfate salt (purchased form Sigma)  is 
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soluble to 20mg/ml in methanol and will remain stable at room temperature for two 
years.  Fluorescently tagged Vinblastine (Invitrogen) can be useful for labeling B-tubulin. 
 
Paclitaxel (aka Taxol), isolated from the needles of Taxus brevifolia, stabilizes 
microtubules in vitro.  In the presence of Paclitaxel, microtubules become resistant to the 
depolyermization effects of calcium, cold, dilution, and many destabilizing drugs (fact 
sheet available 5/15/05 [http://probes.invitrogen.com/]).  By binding the inside of 
microtubules (via pores in the surface), Paclitaxel stimulates microtubule polymerization.  
Paclitaxel also has the ability to promote nucleation of microtubules and reduce the 
critical concentration of tubulin to nearly zero at equilibrium (Wilson et al., 1999).  Cells 
incubated with Paclitaxel are halted in the G2 or M phase of the cell cycle (fact sheet 
available 5/15/05 [http://probes.invitrogen.com/]).  Unlike Demecolcine, the effects of 
the drug persist well after the removal of the agent from the system.  Paclitaxel is soluble 
in DMSO, MeOH, and EtOH and should be stored at -20
o
C protected from light for no 
more than a month. Invitrogen offers several Paclitaxel conjugates that will fluoresce in 
either the green, red, or orange range.  A typical working concentration of unlabeled 
Paclitaxel is 0.1uM and 1uM for labeled Paclitaxel. 
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Materials and Methods 
 All animals were handled under the strict guidelines dictated by the Institutional 
Animal Care and Use Committee (IACUC) of Worcester Polytechnic Institute.   
Oocyte collection 
 In order to induce superovulation in donor mice, female CF-1 mice (Charles River 
Laboratories) of breeding age were injected with Pregnant Mare Serum Gonadotropin 
(PMSG, Calbiochem) and Human Chorionic Gonadotropin (hCG, Calbiochem).  For both 
hormones, 5IU was administered per mouse via intraperitioneal injection.  PMSG was 
injected 64 hours before collection and hCG was given 48 hours later.  Oviducts were 
dissected from mice euthanized by CO2 asphyxiation and placed in FHM media 
(Chemicon, see APPENDIX for composition) at 37
o
C.  Oocytes were separated from 
surrounding cumulus cells by a brief exposure to bovine hyaluronidase (HA, Sigma, 
150units/ml, <10 minutes).   Oocytes with poor morphology (lysed, fragmented, dark 
pigmentation) were discarded.  Oocytes were washed three times in FHM media and 
randomly sorted into treatment groups.  Some oocytes were immediately fixed (see 
below) at metaphase of meiosis II (MII).   
 
Oocyte activation 
 Oocytes were activated with either a 5 minute incubation in 7% ethanol or a 
continuous exposure to 10mM strontium chloride (SrCl2, Sigma), and fixed at specific 
points in development.  
 For ethanol activation, all procedures were accomplished at 37
o
C.  Denuded 
oocytes were washed 3 times in FHM and transferred to FHM containing 7% absolute 
ethanol.  After 5 minutes, oocytes were washed 4 times with FHM, 3 times in KSOM 
(+aa, Chemicon, see APPENDIX for composition), and incubated in KSOM at 37
o
C in 
5% CO2.  After 10 minutes, some oocytes were transferred to FHM containing 0.4ug/ml 
Demecolcine (Sigma).  
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 For SrCl2 activation, the denuded oocytes were washed 3 times in FHM, 3 to 4 
times in KSOM (without Ca
+2
, Chemicon, see APPENDIX for composition) equilibrated 
to 37
o
C in 5% CO2, and then incubated in KSOM containing 10mM strontium chloride at 
37
o
C with 5% CO2.  After 15 minutes, some oocytes, depending on experimental design, 
were transferred to KSOM containing both SrCl2 (10mM) and Demecolcine (0.4ug/ml) 
and incubated at 37
o
C with 5% CO2.   
Oocyte fixation 
Depending on experimental requirements, oocytes were either fixed at metaphase 
of meiosis II (MII) immediately following the FHM wash or activated and fixed at t=25 
minutes, t=125 minutes,  t=245 minutes for anaphase II, telophase II, and interphase 
respectively.  The initial exposure to EtOH or SrCl2 was considered T0.  For comparison 
purposes, oocytes were fixed in either 2% paraformaldehyde (PFA) solution containing 
0.1% Triton X-100 or Microtubule Stabilization Buffer- Extraction Fixative (MTSB-XF, 
see APPENDIX for composition; (Mattson et al., 1990)).  Oocytes remained in fix 
solution for a minimum of 30 minutes at 37
o
C and then transferred to Blocking Buffer 
(block, Allworth & Albertini, 1993; see APPENDIX for composition) for storage at 4
o
C. 
  
Oocyte staining and imaging 
 To localize Apc11, a polyclonal antibody raised in rabbits against N-terminal 
amino acids of human APC11 (Santa Cruz) was used as a primary antibody.  Oocytes 
were then washed 3 times with Phosphate Buffered Saline containing 0.1% 
Polyvinylpyrrolidone (PBS/PVP, Sigma) at room temperature and blocked with Blocking 
Buffer (block) for at least 30 minutes at room temperature.  Apc11 was then probed with 
a goat anti-rabbit IgG antibody labeled with Alexa fluor 488 (5ug/ml in Blocking Buffer, 
green, Molecular Probes) and extensively washed with PBS/PVP.  Microtubules were 
localized using a 1:1 mixture of primary monoclonal antibodies raised against tubulin 
and tubulin (Sigma, 1:1000 dilution in Blocking Buffer, see APPENDIX), washed 3 
times with PBS/PVP, blocked for at least 30 minutes with Blocking Buffer, and 
visualized with a goat anti-mouse IgG1 secondary antibody labeled with Alexa fluor 594 
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(5ug/ml in Blocking Buffer, red, Molecular Probes).  Oocytes were subsequently washed 
with PBS/PVP and chromatin was visualized by exposure to Hoechst 22358 (10ug/ml in 
block, blue, Molecular Probes).  Oocytes were mounted on glass slides in 25ul mounting 
solution (50% glycerol, 50% PBS, 25mg/ml sodium azide), covered with cover glass 
(22x22mm, #1, Fisher Scientific), and sealed with clear nail polish (New York Color 
Inc.).  Imaging was accomplished on a Zeiss Axiovert 200M inverted fluorescence 
microscope coupled to a Roper CoolSnapFx camera through a 63x oil emersion objective 
and 10x eyepiece/camera lens.  Metamorph and Axiovision image processing software 
was used to collect micrographs.  
 To visualize Cdc20, the protocol was similar to the visualization of Apc11 with 
different antibodies.  The anti-cdc20 antibody (Santa Cruz) was raised in rabbits against 
amino acids mapping to the N-terminal of human p55 (CDC20).  The secondary was a 
goat anti-rabbit IgG labeled with Alexa fluor 594 (5ug/ml in Blocking Buffer, red, 
Molecular Probes).  Since a red Alexa 594 secondary was used to label cdc20, the tubulin 
secondary was switched to goat anti-mouse IgG1 labeled with Alexa fluor 488 (5ug/ml in 
Blocking Buffer, green, Molecular Probes).   
 For Rec8 staining, a similar procedure was followed. The polyclonal anti-Rec8 
was raised in goats against amino acids mapping to the N-terminus of human Rec8 (Santa 
Cruz Biotech., sc-15152).  The secondary was a donkey anti-goat IgG labeled with Alexa 
594 (5ug/ml, red, Molecular Probes).  Tubulin visualization was accomplished using 
Alexa fluor 488 (5ug/ml, green, Molecular Probes) as a secondary.  To reduce tubulin 
staining, the tubulin cocktail was used at a 1:2000 dilution throughout the Rec8 
staining protocol.  In order to avoid non-specific binding, the blocking solution used 
throughout Rec8 staining contained no goat serum (see APPENDIX for complete 
composition).   
A minimum of 10 eggs were imaged for every treatment with each antibody.  
Unless otherwise stated, all images presented were representative of the group with little 
egg to egg variation.   
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Antibody optimization 
 Because the three primary antibodies have not been well characterized in mouse 
oocytes, it was first necessary to optimize the staining protocol.  The same optimizing 
protocol was followed for each antibody.   
 
Hela cell culture  
The first step in the optimization process was to determine the localization pattern 
in Hela cells.  The Hela cell culture was grown according to ATCC biosafety level 2 
regulations in Minimum Essential Media, Eagle Salts (EMEM) with 10% Fetal Bovine 
Serum and penicillin/streptomycin at 37
o
C under 5% CO2.  When cells were at or above 
85% confluence, cultures were split 1:8.  Cells were seeded on glass slides at 25% 
confluence, synchronized with a Thymidine/ Hydroxyurea protocol according to Takita et 
al. (2003), and fixed in MTSB-XF for 1 hour at room temperature.  Detailed split and 
synchronization protocols can be found in the APPENDIX.  Fixed cells were stored in 
Blocking Buffer at 4
o
C. 
Synchronized and unsynchronized cells were stained for the presence and 
localization of Apc11, Cdc20, or Rec8.  Initially, cells were incubated in varying 
concentrations of each primary antibody (1:1000, 1:500, 1:200) for 1 hour at room 
temperature.  The cells were washed 2 times with PBS/PVP and incubated in the 
corresponding secondary antibody tagged with Alexa fluor 594 (5ug/ml in Blocking 
Buffer) for 1 hour at room temperature. The cells were then washed again and subjected 
to a brief (~15 minutes) incubation in Hoechst 22358 (g/ml) to stain DNA.  As 
negative controls, some cells were incubated in PBS in lieu of either primary or 
secondary antibody.   
 
Concentration study 
Once an ideal concentration was determined in Hela cells, this information was 
used to optimize the staining protocol for mouse oocytes.  All optimization studies were 
conducted with oocytes arrested at MII and randomly assorted into treatment groups.  
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The same optimization procedure was followed for Apc11, Cdc20, and Rec8.   Oocytes 
were incubated in one of several concentrations of primary antibody (1:100, 1:200, 1:500, 
1:1000, 1:2000, 1:4000 in Blocking Buffer) before being imaged.  Additionally, the 
incubation time and temperature was varied (1 hour at room temperature, 1 hour at 37
o
C, 
overnight at 4
o
C).  As negative controls, Blocking Buffer was substituted for either 
primary or secondary antibody for some oocytes.  Following the incubations, the oocytes 
were imaged and the optimal protocol was determined (listed previously in Materials and 
Methods). 
Following the concentration study, it was determined that an incubation in a 
1:2000 dilution of anti-Apc11 overnight at 4
o
C was optimal for Apc11 localization.  For 
Cdc20, a 1 hour incubation at room temperature in 1:250 was ideal.  For Rec8, a 1:100 
dilution of primary antibody in Blocking Buffer was used.   
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Results 
Part I: Antibody validation 
D 
Since the localization of the Anaphase Promoting Complex, specifically subunits 
Apc11 and Cdc20, has not been well studied in mouse oocytes, it was first necessary to 
validate the antibodies in a well characterized system like HeLa cells.  Cells fixed in 
MTSB-XF were stained for either Apc11 or Cdc20 (red) and counterstained with Hoechst 
22358.  As a negative control, some cells underwent an identical staining procedure 
substituting blocking solution for the secondary antibody (Figure 3A-C) or primary 
antibody (Figure 3D).  Cells in negative control experiments appeared as dull, non-
distinct red hazes (Figure 3).   
 
Figure 3 - Negative control images of Hela cells 
Unsynchronized Hela cells were imaged without secondary or primary antibodies in the staining protocol: 
Apc11 alone (A), Cdc20 alone (B), Rec8 alone (C), or Alexa594 Goat anti-Rabbit IgG alone (D).   DIC 
images (left) are shown with 5ms exposure; Red fluorescence images (right) are shown with a 100 ms 
exposure.  Single cells are circled with a white dash.  The background has been set to black.   
 
 
In non-dividing (G2) cells, Apc11 appeared both cytoplasmically and in the 
nucleus (Figure 4A).  However, the staining pattern was quite different in dividing cells.  
Apc11 colocalized with the kinetochores during prophase (orange arrows) and the 
A 
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mitotic spindle during metaphase (yellow arrow).  This result is consistent with the report 
of Acquaviva et al. (2004), who demonstrated a similar localization for Apc3 (Figure 5).  
 
 
Figure 4 - Localization of APC subunits in unsynchronized HeLa cells.  
Apc11 (A) and Cdc20 (B) are shown in red. Hoechst 22358 (Chromatin) is shown in blue.  Evidence of 
colocalization is purple.  G2 cells show a cytoplasmic distribution of APC subunits while cells undergoing 
cellular replication show evidence of colocalization around the chromatin. Orange arrows point to the 
kinetochores in prophase cells.  Yellow arrows point to a cell in metaphase.  Red fluorescence is imaged 
with a 100 ms exposure. 
B 
A 
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 For Cdc20, the localization pattern is very similar (Figure 4B).  In non-dividing 
(G2) cells, dim cytoplasmic and nuclear staining is detected.  Once the cells enter mitosis, 
the anti-Cdc20 is significantly more detectable around the dividing sister chromatids, 
though not directly on the spindle fibers as in the Apc11 staining (yellow arrows).  This is 
also consistent with previous work (Clute & Pines, 1999).   
 
 
Figure 5 - Published images of APC3 localization (Acquaviva et al. 2004) 
APC3 (left panel, green) was localized in synchronized Hela cells.  CREST staining of centromeres is 
shown in the middle panels.  The right panel is the merge of the two.  At prophase (A), APC3 staining is 
detected at the kinetochores while at metaphase (B), staining is detected at the mitotic spindle.    
 The anti-Rec8 antibody was also initially validated with HeLa cells.  Rec8 has 
been known to be a highly regulated protein (reviewed by Watanabe et al., 2005).  It has 
been previously demonstrated that, while at metaphase Rec8 is highly associated with the 
chromosomes, Rec8 is soon cleaved and disperses throughout the cytoplasm.  This is 
similar to the localization pattern seen in Figure 6.  HeLa cells were grown on coverglass 
to 75% confluence and fixed in 2% PFA with Trition X-100.  Cells were stained for Rec8 
(red) and chromatin (blue).  Non-replicative cells appear show a non-distinct cytoplasmic 
Rec8 staining.  However, the cell at metaphase (yellow arrow) shows bright Rec8 
staining around the chromosomes.   
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Figure 6 - Localization of Rec8 in unsynchronized HeLa cells.   
Anti-Rec8 is stained in red.  Hoechst 22358 (Chromatin) is stained in blue.  At metaphase, Rec8 (red) is 
highly expressed around the chromosomes (blue) aligned around the metaphase plate (yellow arrow).  In 
non-dividing cells, Rec8 staining is less distinct in the cytoplasm.  Red fluorescence is imaged with a 100 
ms exposure. 
 
Part II: Optimization 
Dilution study 
 Once the antibodies were validated, it was then necessary to optimize the staining 
protocol in a mouse oocyte system.  In order to determine the ideal experimental 
conditions, staining variables such as primary antibody concentration, incubation 
temperature, and duration all needed to be addressed.  In brief, a series of experiments 
was designed such that primary concentration, incubation time, and temperature were 
individually varied.  A similar process was completed for the optimization of Apc11 
(Figure 8), Cdc20 () and Rec8 (data not shown).  The detailed experimental design is 
provided in the Methods and Materials section.   
 Figure 7 shows representative results of negative control experiments.  To 
generate these images, oocytes were subjected to the same staining protocol listed in the 
Materials and Methods section without the addition of secondary antibody (Figure 7B-D).  
Figure 7A shows an egg stained with neither primary nor secondary antibodies.  In all 
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oocytes, low levels of non-distinct staining could be detected.  It was this base level of 
fluorescence to which all subsequent images were compared.   
The pictures in Figure 8 are representative of the optimization study for Apc11.  
Oocytes were fixed at metaphase of meiosis II in 2% PFA with Triton X-100.  Apc11 
appears in green.  Chromatin stained with Hoechst 22358 appears blue.  Tubulin (meiotic 
spindle) is stained red.  In samples incubated in high concentrations of anti-Apc11 (every 
dilution tested below 1:1000, data not shown), the staining pattern was that of complete 
saturation.  Camera saturation occurs when pixel values exceed the range of the camera 
and are assigned as white.  
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Figure 7 - Negative control images of oocytes 
Oocytes were imaged without the addition of secondary and/or primary antibodies in the staining protocol: 
neither primary nor secondary antibody (A), Apc11 alone (B), Cdc20 alone (C), or Rec8 alone(D) without 
the addition of secondary antibody.  DIC images (left) are shown with 5ms exposure; fluorescence images 
(right) are shown with a 150 ms exposure.  The background has been set to black. 
A
’ 
C 
B 
D 
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Figure 8 - Apc11 staining optimization 
in mouse oocytes.  
Oocytes fixed in 2% PFA with Triton X-
100 were incubated in decreasing 
concentrations (1:1000, top panel), 
(1:2000, middle panel), (1:4000, bottom 
panel) of Apc11 either overnight at 4
o
C 
or for 1 hour at either room temperature 
or 37
o
C.  Oocytes were stained for 
Apc11 (green), Hoechst 22358 (blue), 
tubulin (red).  Oocyte autofluorescence 
appears as a dull green haze.  Scale bars 
are m.   All green fluorescence 
imaged with a 100 ms exposure. 
 
At high concentrations, it was 
impossible to differentiate any 
variation in the pattern within a 
single oocyte or between other 
oocytes (data not shown).  At the 
1:1000 dilution (Figure 8 top 
panel), distinct Apc11 
localization patterns appeared 
within the oocyte (cytoplasmic 
staining, cortical omission, and 
an exclusion zone within the 
meiotic spindle, detailed later).  
As the dilution was increased to 
1:2000 (Figure 8 middle panel), 
these patterns became more 
consistently apparent.  While these 
patterns were still detectable in the 
1:4000 dilution (Figure 8 bottom 
panel), the staining pattern was 
often so dim, that it was difficult 
to discern the antibody from the 
Apc11=green
DNA= blue
tubulin = red
1:1000, RT
1:1000, overnight 4C 
1:1000, RT
1:1000, 37C
1:1000, 37C
 
Apc11=green
DNA= blue
tubulin = red
1:2000, 37C
1:2000, 37C
1:2000, overnight 4C
1:2000, overnight 4C
1:2000, RT
1:2000, RT
 
Apc11=green
DNA= blue
tubulin = red
1:4000, 1 hr RT
1:4000, overnight 4C
1:4000, overnight 4C
1:4000, 1 hr RT
No primary stain
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background auto-fluorescence of the oocyte (shown in Figure 7).  It was therefore 
determined that a 1:2000 dilution of anti-Apc11 was optimal for the purposes of this 
project.   
For this experimental set, secondary antibody conditions were held constant at 5ug/ml.   
 
Figure 9 - Examples of Cdc20 optimization 
Oocytes fixed in 2% PFA with Triton X-100 were incubated in increasing concentrations of primary cdc20 
antibody.  Oocytes were stained for Cdc20 (green), Hoechst 22358 (blue), tubulin (red).  Oocyte 
autofluorescence appears as a dull green haze.  Scale bars are m.   All green fluorescence imaged with a 
100 ms exposure. 
 
Incubation temperature and duration 
 Once a dilution was selected, it was then necessary to determine the optimal 
conditions for temperature and duration of immunostaining.  Oocytes were incubated 
overnight at 4
o
C or for one hour at either 37
o
C or room temperature.  While oocytes 
stained at 37
o
C yielded bright images (Figure 8 middle panel-left), often the signal 
reported by the camera was saturated and therefore may not have been as specific as the 
pictures taken of oocytes incubated at lower temperatures.  In contrast to this, oocytes 
incubated for 1 hour at room temperature (Figure 8 middle panel-middle), were often too 
dim to discern any consistent localization.  Similarly, oocytes stained at 4
o
C overnight 
1:50 1:100 1:200 
1:500 1:1000 1:4000 
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(Figure 8 middle panel-right) were also fairly dim, but localization within these oocytes 
appeared more consistent than those stained at room temperature.  Because of this, an 
overnight incubation at 4
o
C was used for the remainder of the Apc11 studies.   
 
Fixative comparison 
 Another factor that has a profound effect on staining specificity and the imaging 
process is the solution used to fix the oocytes.  Ideally, the fixative should preserve the 
structure of certain aspects of an immobilized cell in order to help predict the utility of 
those aspects in vivo.  For example, if conducting studies on the meiotic spindle, a fix  
Figure 10 - Oocytes fixed with MTSB-XF.   
Oocytes were fixed at MII with MTSB-XF and stained with anti-Apc11 (green), Hoechst 22358 (blue), and 
Phalloidin labeled with Texas Red (red).  While Apc11 localization can still be detected in an exclusion 
zone around the meiotic spindle, the overall staining pattern is non-distinctive.   
 
solution that would preserve the native microtubule structure at a given time while 
simultaneously removing material that would restrict access to the spindle would be 
ideal.  In the mouse system, one such fix is the Microtubule Stabilizing Buffer - 
Extraction Fixative (MTSB-XF) used by (Ibanez et al., 2003) who carefully measured the  
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morphology of the meiotic spindle in response to a variety of stimuli.  Since the anaphase 
promoting complex was known to act in the vicinity of the meiotic spindle, MTSB-XF 
was chosen as the fix solution for the initial studies of the Apc11 antibody.  
Representative results of these initial studies are shown in Figure 10.  Oocytes arrested at 
MII were stained with Anti-Apc11 (green), Hoechst 22358 (blue), and Texas-red 
Phalloidin (red).  Although an Apc11 localization pattern can be detected as an exclusion 
zone surrounding the meiotic spindle, the overall stain is hazy and non-distinctive.  For 
this reason, MTSB-XF was replaced by the PFA solution described in the Methods and 
Materials section as the preferred fixative (compare Figure 10 to Figure 11; detailed 
later).    
Selection of an activation stimulus 
 As oocytes develop, they undergo a complete round of meiosis and then arrest at 
metaphase of meiosis II.  Oocytes will remain in this arrested state until they are ionically 
activated to continue development.  Normally, this stimulus is a periodic calcium signal 
produced by the invading sperm to the oocyte.  However, in order to study the spatial 
localization of the anaphase-promoting complex at different stages of development, this 
signal was initially replicated in vitro with a short incubation in 5% Ethanol.  Ethanol 
causes the formation of inositol 1,4,5-triphosphate at the membrane and a concomitant 
influx of extra-cellular calcium (Ibanez et al., 2005).  However, instead of periodic spikes 
in cytoplasmic calcium concentration, the ethanol causes a prolonged influx of calcium.  
As a result, oocytes activated with ethanol developed inconsistently.  Often, as many as 
50% of eggs per experiment failed to leave MII when activated by a standard ethanol 
protocol (data not shown).  Additionally, eggs that did activate often progressed through 
development too quickly for the cell to properly respond.  Since this phenomenon often 
caused significant egg-to-egg variation in control groups (data not shown), ethanol was 
replaced as an activation stimulus by strontium chloride for all subsequent experiments.     
Part III. Apc11 Localization  
 Demecolcine has been used to aid in the enucleation process for the purposes of 
somatic cell nuclear transfer (Baguisi & Overstrom, 2000).  In order to test the effects of 
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Demecolcine on the spatial localization of Apc11, the catalytic core of the Anaphase-
Promoting Complex, oocytes harvested from hormonally primed CF-1 mice were 
activated in strontium chloride, incubated in the presence of 0.4ug/ml Demecolcine, and 
fixed in PFA solution at specific points of development (AII, TII, Interphase).  Control 
eggs were fixed without ever being exposed to Demecolcine.  The results of these control 
experiments can be found in Figure 11 through Figure 14.  Anti-Apc11 is shown in green.  
Chromatin appears blue.  Tubulin appears red.  Left panels show Apc11 alone; right 
panels are the overlay of the three stains.   
A minimum of 10 eggs were imaged for every treatment with each antibody.  
Unless otherwise stated, all images presented were representative of the treatment group 
with little egg to egg variation.   
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Control activation 
  
Figure 11 - Localization of Apc11 in oocytes arrested at Metaphase of meiosis II (MII).   
Denuded oocytes were fixed in PFA immediately following removal from hyaluronidase and stained for 
Apc11 (green), chromatin (blue), and  tubulin (red).  The left panel shows Apc11 alone; the right panel 
is the overlay of the three stains. Yellow arrows indicate perispindular localization.  Orange arrow indicates 
the hemispheric ridge.  Green fluorescence is imaged at 120ms. 
 
 During meiosis II, Apc11 (green) showed two types of localization.  The most 
prevalent was a strong localization to the area directly surrounding the meiotic spindle 
(Figure 11, yellow arrows).  This perispindular localization persisted from MII (Figure 
11), through AII (Figure 12) and TII (Figure 13) and began to disappear at the onset of 
interphase (Figure 14).  Interestingly, while there existed a high concentration of Apc11 
outside the spindle, there was very little staining in the area directly within the spindle 
(not shown in the focal plane of Figure 11; see Figure 13).  This staining continued to 
surround the chromatin (though less pronouncedly) even after the spindle has moved 
away at Interphase (Figure 14).  The second type of localization occurred only at MII and 
early AII.  Within these oocytes, there appeared to be a discrete staining pattern within 
the hemisphere that contained the meiotic spindle (Figure 11, orange arrow). 
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Figure 12 - Localization of Apc11 in oocytes fixed at Anaphase of meiosis II (AII).   
Denuded oocytes were fixed in PFA 25 minutes after the initiation of activation.  Oocytes were stained for 
Apc11 (green), chromatin (blue), and  tubulin (red).  The left panel shows Apc11 alone; the right panel 
is the overlay of the three stains.  Green fluorescence is imaged at 120ms. 
 
  
Figure 13 - Localization of Apc11 in oocytes fixed at Telophase of meiosis II (TII).   
Denuded oocytes were fixed in PFA 2 hours after the initiation of activation.  Oocytes were stained for 
Apc11 (green), chromatin (blue), and  tubulin (red).  The left panel shows Apc11 alone; the right panel 
is the overlay of the three stains. Green fluorescence is imaged at 120ms. 
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Figure 14 - Localization of Apc11 in oocytes fixed in Interphase.   
Denuded oocytes were fixed in PFA 4 hours after the initiation of activation.  Oocytes were stained for 
Apc11 (green), chromatin (blue), and  tubulin (red).  The left panel shows Apc11 alone; the right panel 
is the overlay of the three stains. Green fluorescence is imaged at 120ms. 
 
Effects of Demecolcine on Apc11 spatial localization 
 Once the spatial localization of Apc11 following a standard parthenogenetic 
activation was established, it was then possible to determine what effects Demecolcine 
may have on its localization.  Oocytes were incubated 10 minutes in strontium chloride 
before they were transferred into media containing both strontium chloride and 
Demecolcine (0.4ug/ml).  The results of these experiments can be found in Figure 15 
through Figure 17.  Anti-Apc11 is shown in green.  Chromatin appears blue.  Tubulin 
appears red.  Left panels show Apc11 alone; right panels are the overlay of the three 
stains.   
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Figure 15 - Effects of Demecolcine on Apc11 localization in oocytes fixed at AII. 
Denuded oocytes were incubated in 10mM SrCl2 for 10 minutes followed by a 15 minute incubation in 
media containing 10mM SrCl2 and 0.4ug/ml Demecolcine.  (left panel) Apc11 alone.  (right panel) Overlay 
of Apc11 (green), Hoechst 22358 (blue), and tubulin (red).   Green fluorescence is imaged at 120ms.  
 
 As seen in Figure 15, the Demecolcine destabilized the microtubules within the 
cell.  As a result, the meiotic spindle was severely disrupted compared to control eggs at 
the same time (see Figure 12) and tubulin (red staining) was detected throughout the 
cytoplasm.  Furthermore, a longer incubation in Demecolcine caused more of the 
microtubules to disassociate from the spindle (compare red staining in Figure 15 to 
Figure 17).  Because the spindle was disrupted, sister chromatids often did not segregate 
properly and only a single cluster of DNA was observed well after the activation 
stimulus.  Eventually, the oocyte completely extrudes its chromatin in the second polar 
body (Figure 17).   
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Figure 16 - Effects of Demecolcine on Apc11 localization in oocytes fixed at TII. 
Denuded oocytes were incubated in 10mM SrCl2 for 10 minutes followed by a 110 minute incubation in 
media containing 10mM SrCl2 and 0.4ug/ml Demecolcine.  (left panel) Apc11 alone.  (right panel) Overlay 
of Apc11 (green), Hoechst 22358 (blue), and tubulin (red).    Green fluorescence is imaged at 120ms. 
 
 Since the spatial localization of many key cell cycle proteins is closely associated  
to the meiotic spindle, it was hypothesized that the disruption of that spindle could 
negatively affect subunits of the APC as well.  As Figure 15 through Figure 17 show, the 
disruption of the meiotic spindle did cause a concomitant loss of Apc11 localization.  
Apc11 localization in mouse eggs is characterized by an aggregation of protein directly 
around the spindle.  However, in eggs treated with Demecolcine, the staining pattern 
changed to a non-distinct ataxia across the entire oocyte with no evidence of 
colocalization in any stage of development.  
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Figure 17 - Effects of Demecolcine on Apc11 localization in oocytes fixed at Interphase. 
Denuded oocytes were incubated in 10mM SrCl2 for 10 minutes followed by a 230 minute incubation in 
media containing 10mM SrCl2 and 0.4ug/ml Demecolcine.  (left panel) Apc11 alone.  (right panel) Overlay 
of Apc11 (green), Hoechst 22358 (blue), and tubulin (red).    Green fluorescence is imaged at 120ms. 
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Part IV. Cdc20 Localization 
 In the regulation of development, Cdc20 has the dual role of both an activator of 
the Anaphase Promoting Complex and a substrate of the ubiquitin-assisted destruction 
pathway.  During metaphase of mitosis, Cdc20 binds to the APC allowing for the 
ubiquitination of securin.  Once the cell progresses beyond early anaphase, Cdc20 
disassociates from the complex and is soon destroyed.  In order to determine if this 
pattern in mitosis correlates to meiotic cells, Cdc20 was localized in mouse eggs with a 
commercially available polyclonal antibody.    
Control activation 
 Oocytes were harvested from the oviducts of hormonally primed CF-1 mice and 
separated from the surrounding cumulus mass with bovine hyaluronidase (HA).  Denuded 
oocytes were either fixed immediately at metaphase of meiosis II or activated with 10mM 
strontium chloride and fixed later in development in 2% PFA with Triton X-100 (AII, 
TII, Interphase).  Oocytes were stained for Cdc20 (red), chromatin (blue), and 
tubulin (green).  
 
  
Figure 18 - Localization of Cdc20 in oocytes fixed at MII. 
Denuded oocytes were fixed immediately following removal from hyaluronidase.  (left panel) Cdc20 alone.  
(right panel) Overlay of Cdc20 (red), Hoechst 22358 (blue), and tubulin (green).  At MII, Cdc20 
stained shows punctate spots throughout the cytoplasm.  Red fluorescence is imaged at 100ms. 
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 At MII, Cdc20 staining (red) appeared as punctate spots seemingly randomly 
distributed throughout the cytoplasm.  Therefore, unlike Apc11, Cdc20 did not appear to 
localize to the vicinity of the meiotic spindle in metaphase.  This variegate staining 
disappeared early after activation.  At AII, the staining pattern changed to a more diffuse 
cytoplasmic distribution across the cell (see Figure 19).  By TII (Figure 20), Cdc20 
staining has all but disappeared, with only a faint haze remaining across the cytoplasm.  
This miasma is indistinguishable from the natural autofluorescence of oocytes fixed with 
PFA (data not shown).  Interestingly, Cdc20 staining reappears in oocytes fixed in 
Interphase (Figure 21).  At this point in development, Cdc20 localizes strongly to the 
pronucleus (yellow arrow) and diffusely to the cytoplasm.  This cytoplasmic staining is 
comparable to the staining observed at AII (compare Figure 21 to Figure 19).   
  
  
Figure 19 - Localization of Cdc20 in oocytes fixed at AII. 
Denuded oocytes were fixed after a 25 minute incubation in 10mM SrCl2.  (left panel) Cdc20 alone.  (right 
panel) Overlay of Cdc20 (red), Hoechst 22358 (blue), and tubulin (green).  At AII, Cdc20 staining 
shows diffuse cytoplasmic localization. Red fluorescence is imaged at 150ms. 
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Figure 20 - Localization of Cdc20 in oocytes fixed at TII. 
Denuded oocytes were fixed after a 1 hour incubation in 10mM SrCl2.  (left panel) Cdc20 alone.  (right 
panel) Overlay of Cdc20 (red), Hoechst 22358 (blue), and tubulin (green).  At TII, Cdc20 staining 
shows a dim cytoplasmic haze not significantly brighter than background autofluoresce (data not shown).  
Red fluorescence is imaged at 250ms. 
 
  
Figure 21 - Localization of Cdc20 in oocytes fixed at Interphase. 
Denuded oocytes were fixed after a 4 hour incubation in 10mM SrCl2.  (left panel) Cdc20 alone.  (right 
panel) Overlay of Cdc20 (red), Hoechst 22358 (blue), and tubulin (green).  Red fluorescence is 
imaged at 150ms. 
 
 
Effects of Demecolcine on Cdc20 localization 
 In order to determine if the localization of Cdc20 is affected by an incubation in 
Demecolcine, oocytes harvested from hormonally primed CF-1 mice were fixed at 
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various stages of development in the presence or absence of Demecolcine and stained for 
Cdc20 (red),  tubulin (green), chromatin (blue).    
Similar to observations with Apc11, the Demecolcine caused a severely disrupted 
spindle and the associated cytoplasmic distribution of tubulin and, as the Demecolcine 
incubation duration was increased, these effects became more prevalent.  Also, just as 
Apc11 was not localized after Demecolcine incubation, so too was Cdc20 affected.  
While in control eggs, Cdc20 staining levels varied greatly throughout development, 
nearly disappearing during TII (compare the exposure times of Figure 18 through Figure 
21), no such diminution was detected in eggs treated with Demecolcine.  As seen in 
Figure 22, eggs incubated with Demecolcine showed low levels of patchy aggregate 
staining across the cytoplasm.  This pattern persisted throughout development.  Thus, the 
incubation in Demecolcine eliminated the cyclic staining pattern observed in control 
eggs.   
 
  
Figure 22 - Effects of Demecolcine on Cdc20 localization in oocytes fixed at AII. 
Denuded oocytes were incubated in 10mM SrCl2 for 10 minutes followed by a 15 minute incubation in 
media containing 10mM SrCl2 and 0.4ug/ml Demecolcine.  (left panel) Cdc20 alone.  (right panel) Overlay 
of Cdc20 (red), Hoechst 22358 (blue), and tubulin (green).    Red fluorescence is imaged at 100ms. 
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Figure 23 - Effects of Demecolcine on Cdc20 localization in oocytes fixed at TII. 
Denuded oocytes were incubated in 10mM SrCl2 for 10 minutes followed by a 110 minute incubation in 
media containing 10mM SrCl2 and 0.4ug/ml Demecolcine.  (left panel) Cdc20 alone.  (right panel) Overlay 
of Cdc20 (red), Hoechst 22358 (blue), and tubulin (green). Red fluorescence is imaged at 100ms. 
 
  
Figure 24 - Effects of Demecolcine on Cdc20 localization in oocytes fixed at Interphase. 
Denuded oocytes were incubated in 10mM SrCl2 for 10 minutes followed by a 230 minute incubation in 
media containing 10mM SrCl2 and 0.4ug/ml Demecolcine.  (left panel) Cdc20 alone.  (right panel) Overlay 
of Cdc20 (red), Hoechst 22358 (blue), and tubulin (green). Red fluorescence is imaged at 100ms. 
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Part V: Rec8 Localization  
 With the knowledge that Demecolcine can affect both the spatial localization of 
Apc11, the catalytic core of the Anaphase-Promoting Complex, and the orderly 
destruction of Cdc20, a main activator of the APC, one can postulate that the activity of 
the APC could also be affected by an incubation in Demecolcine.  In order to determine 
the magnitude of such an effect, the spatial localization of Rec8 was examined. 
 Rec8 is a meiosis specific subunit of the cohesion complex.  In order for a cell to 
leave metaphase, the APC driven disassembling of the cohesion complex surrounding 
sister chromatids must occur.  The APC, activated by Cdc20, ubiquitinates securin 
marking it for destruction by the 26S proteasome.  The destruction of securin activates 
separase to open the cohesion complex by the cleavage of the subunit Rec8.  Therefore, 
the spatial localization of Rec8 in relation to cellular chromatin could potentially serve as 
an indirect measure of downstream APC activity.  
Control activation experiments 
 Since Rec8 localization has not been well characterized in mouse oocytes, it was 
first necessary to determine the staining pattern in oocytes fixed and activated with a 
standard parthenogenetic protocol.  Denuded oocytes were harvested from hormonally 
primed CF-1 mice and fixed in 2% PFA with Triton X-100 either immediately after 
removal from hyaluronidase or activated with 10mM strontium chloride and fixed later in 
development.  They were then stained for chromatin (blue) with Hoechst 22358 and Rec8 
(red) with a commercially available Donkey anti-goat polyclonal antibody (Santa Cruz 
Biotechnologies).    
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Figure 25 - Spatial localization of Rec8 in oocytes arrested at MII. 
Denuded oocytes were fixed immediately following removal from hyaluronidase.  Overlays of Rec8 (red) 
and Hoechst 22358 (blue).  At MII, Rec8 localizes to the cortical region directly overlying the condensed 
chromatin in both the meiotic spindle (yellow arrows) and first polar body (orange arrow). Red 
fluorescence is imaged at 120ms. 
 
 Anti-Rec8 staining appears to localize to the vicinity of cellular chromatin in 
several ways.  Firstly, Rec8 localizes to the membrane surrounding the first polar body 
(Figure 25; right panel, orange arrow and Figure 26; bottom panel, aqua circle).  This 
staining can be seen in all oocytes in which the polar body contains distinguishable 
chromatin.  However, in oocytes where the chromatin within the polar body has begun to 
deteriorate, there is no evidence of Rec8 polar body localization (data not shown).   
Secondly, during MII, Rec8 is sequestered to the cortical region directly overlying 
the metaphase plate (Figure 25; yellow arrows).  As the sister chromatids begin to 
separate early in AII, this cortical staining splits as well (Figure 26; top panel) remaining 
closely tied to both sets of chromosomes.  As anaphase progresses into telophase (Figure 
26; middle and bottom panels), it becomes apparent that Rec8 localizes to both the 
female pronucleus and the budding second polar body.  This localization continues 
though Telophase II (Figure 27) until Interphase when Rec8 becomes partially 
sequestered within the pronucleus (Figure 28; yellow arrow).    
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Figure 26 - Spatial localization of Rec8 in oocytes fixed at AII. 
Denuded oocytes were fixed after a 10 minute (top panel), 20 minute (middle panel), and a 40 minute 
(bottom panel) incubation in 10mM SrCl2.  Overlays of Rec8 (red) and Hoechst 22358 (blue).  During 
anaphase II, Rect8 localizes to an area surrounding chromatin that will become the female pronucleus 
(yellow arrows) and the chromatin that is to be extruded in the second polar body (orange arrows). The 
first polar body is highlighted with an aqua dashed circle. Red fluorescence is imaged at 120ms. 
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Figure 27 - Spatial localization of Rec8 in oocytes fixed at TII. 
Denuded oocytes were fix in PFA after a 2 hour incubation in 10mM SrCl2. Rec8 is shown in red.  
Chromatin (Hoechst 22358) is shown in blue.  In TII eggs, Rec8 localized around the female pronucleus 
and the budding second polar body (similar to the late anaphase oocyte in Figure 26.) Red fluorescence 
is imaged at 120ms. 
 
  
Figure 28 - Spatial localization of Rec8 in oocytes fixed at Interphase.  
Denuded oocytes were fixed after a 4 hour incubation in 10mM SrCl2.  Rec8 alone (left panel).  Overlay of 
Rec8 (red) and Hoechst 22358 (blue) (right panel).  During interphase, some Rec8 remains localized to the 
female pronucleus (yellow arrow) whereas some disperses throughout the cytoplasm. Red fluorescence is 
imaged at 200ms. 
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The effects of Demecolcine on Rec8 localization 
 Incubation in Demecolcine affected Rec8 localization within mouse oocytes.  
During anaphase, when the Rec8 normally demonstrated cortical staining directly above 
the chromatin, Rec8 appeared to aggregate in an area surrounding the chromatin, but not 
directly over it (Figure 29).  Later in development, the Rec8 staining pattern changed.  
Interestingly, during telophase, Rec8 staining moved from an area near the chromatin to 
direct colocalization (purple spots) with the chromatin (Figure 30; yellow arrows).  This 
direct localization continued into interphase as the cell extruded its chromatin in the 
second polar body (see Figure 31).   
  
Figure 29 - The effect of Demecolcine on Rec8 localization in oocytes fixed at AII. 
Oocytes were incubated for 10 minutes in 10mM SrCl2 followed by a 10 minute incubation in media 
containing both SrCl2 and 0.4ug/ml Demecolcine before being fixed at AII.  Rec8 alone (left panel).  
Overlay of Rec8 (red) and Hoechst 22358 (blue) (right panel).  Note the localization of Rec8 near the 
chromatin but not directly on it. Red fluorescence is imaged at 120ms. 
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Figure 30 - The effect of Demecolcine on Rec8 localization in TII eggs. 
Oocytes were incubated for 10 minutes in 10mM SrCl2 followed by a 70 minute incubation in media 
containing both SrCl2 and 0.4ug/ml Demecolcine before being fixed at TII.  Overlays of Rec8 (red) and 
Hoechst 22358 (blue).  In TII eggs treated with Demecolcine, Rec8 colocalizes (yellow arrows) directly 
with chromatin (not the surrounding area).  Red fluorescence is imaged at 150ms. 
 
  
Figure 31 - The effect of Demecolcine on Rec8 localization in oocytes fixed in Interphase. 
Oocytes were incubated for 10 minutes in 10mM SrCl2 followed by a 230 minute incubation in media 
containing both SrCl2 and 0.4ug/ml Demecolcine.  Rec8 alone (left panel).  Overlay of Rec8 (red) and 
Hoechst 22358 (blue) (right panel).  Rec8 appears to show some localization directly on the chromatin 
(similar to Figure 30). Red fluorescence is imaged at 150ms. 
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Discussion 
The effects of Demecolcine on the APC  
Demecolcine has previously been used to assist in the enucleation of mammalian 
oocytes for nuclear transfer experiments.  In order to better understand the efficacy of this 
process in early development, three key cell cycle regulation proteins (Apc11, Cdc20, 
and Rec8) were localized in developing mouse embryos in the presence or absence of 
Demecolcine.  It was the working hypothesis of this project that, since these three 
proteins have been previously described to associate with the meiotic spindle (Harper et 
al., 2002; Acquaviva et al., 2004; Castro et al., 2005), the disruption of the spindle would 
affect the localization of these proteins.  
As described earlier, the data from the Apc11 localization experiments suggest 
striking effects of Demecolcine on APC localization.  Although Apc11 strongly localized 
to the perispindular region of the cytoplasm in control oocytes (those incubated in the 
absence of Demecolcine), in Demecolcine treated eggs, no localization was observed.  
From these data, one can postulate that without a well organized meiotic spindle, the 
anaphase promoting complex has nothing around which it will conglomerate. Thus, the 
localization of Apc11 may be tied directly to the integrity of the meiotic spindle.   
 Although Cdc20 was not shown to localize to the meiotic spindle in control 
oocytes, the data from the Cdc20 localization experiments also show pronounced effects 
of Demecolcine on the APC.  In the control activation, Cdc20 localization consistently 
weakened from punctate cytoplasmic staining at MII to a dim, diffuse pattern after 
activation.  Cdc20 localization continued to diminish through TII only to intensify again 
at interphase.  This cyclic pattern is consistent with previous studies regarding Cdc20’s 
role as both activator and substrate of the anaphase promoting complex (Zacharaie et al., 
1999; and many others; see Figure 2).  However, in oocytes incubated in Demecolcine, 
no developmental variation could be detected.  Therefore, one could conjecture that 
Demecolcine has in some way affected the APC’s ability to function properly in the 
orderly binding and destruction of Cdc20.     
It is possible that a loss of APC localization caused by the disruption of the 
spindle could be accompanied by a concomitant loss of APC activity.  It has been 
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hypothesized that the APC ubiquitinates proteins by bringing them into direct contact 
with the E2 enzyme (Harper, et al., 2002; Kraft et al., 2003; Passmore & Barford, 2004; 
Castro et al., 2005).  In order to do this, it is necessary for the APC to be in direct contact 
with the substrate.  By reducing the concentration of Apc11 around segregation 
chromosomes (as seen in Figure 15through Figure 17), an incubation in Demecolcine 
could limit the ability of the complex to make contact with substrates in that area, thus, 
preventing ubiquitination of key cell cycle proteins.  While this may or may not affect the 
ubiquitination of securin, which has yet to be localized to the meiotic spindle, it could 
certainly affect cyclin B, whose destruction inactivates MPF, and other substrates vital to 
the regulation of the cell cycle known to localize to the perispindular region.   
In order to test directly the effects of Demecolcine on APC activity, a series of 
ubiquitination and deubiquitination assays could be designed.  Based on the protocol by 
Rape et al. (2006), the ability of the APC to ubiquitinate APC substrates could be closely 
examined both in the presence and absence of Demecolcine.  Given the effect of 
Demecolcine on APC localization, one would predict that the ubiquitination of several 
cell cycle proteins in the vicinity of the meiotic spindle would also be affected while the 
ubiquitination of those not localized to the spindle would not be severely disturbed.  If the 
results of such experiments did in fact show a disruption or reduction in the 
ubiquitination of cyclin B (localized to the spindle) but not securin (evenly distributed 
throughout the cytoplasm), it could provide further evidence that the APC-regulated 
addition of ubiquitin is indeed a proximity reaction.  
The data from the Rec8 localization experiments also indicate a subtle 
consequence of an incubation in Demecolcine.  In control oocytes, Rec8 consistently 
localized to the region of the cortex directly above chromosomal DNA.  However, in 
Demecolcine treated oocytes, Rec8 appears to amass to the area directly surrounding the 
chromatin, not in the cortical region above it.  Additionally, Rec8 localization appears in 
a direct colocalization with the chromatin following activation.  Since this direct 
colocalization was not observed in control cells, one can postulate that perhaps the 
meiotic spindle in some way shields Rec8 from the DNA and the destruction of that 
spindle frees the chromatin from the protection of the spindle.    
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With regards to the use of Rec8 as an indirect indicator of APC activity, these 
results could be interpreted in several ways.  Although Rec8 did follow a consistent 
staining pattern in control eggs, this pattern differed slightly from the localization 
expected.  The main function of Rec8 has been shown in mitotic cells to be the 
maintenance of the cohesion complex structure at the metaphase plate.  The cleavage of 
Rec8 at the onset of anaphase opens the cohesion ring allowing the proper segregation of 
sister chromatids (reviewed by Revenkova & Jessberger, 2005).  Given this function, one 
would predict a strong colocalization with cellular chromatin at metaphase which would 
disappear at the onset of anaphase.  Since this direct localization and destruction is not 
observed, it is possible that Rec8 might serve a different function in the mouse oocyte 
system and Rec8 would have been a less-than-ideal choice for an indirect indicator of 
APC activity.   
The differences between the predicted and observed Rec8 data are not all that 
surprising.  The prediction was originally based on observations made of Scc1, another 
member of the kleisin family, in cells undergoing mitosis, not meiosis.  At mitotic 
metaphase, Scc1 localizes directly with the condensed chromatin. At the onset of mitotic 
anaphase, Scc1 is cleaved by separase, the same enzyme known to be responsible for the 
excision of Rec8 in meiosis, and disperses throughout the cytoplasm where is it degraded.  
Because of the similarities between Rec8 and Scc1, one would predict that the two 
proteins would localize in a similar manner.  However, a different localization pattern 
was observed for Rec8.  Perhaps this pattern can be attributed to the inherent differences 
in the meiotic versus mitotic mechanisms among which are the symmetrical division of 
the cytoplasmic material, the idiosyncratic gene expression of meiotic cells, and 
dissolution of SMC complexes in oocytes from arm to centromere (Reviewed by 
Revenkova & Jessberger, 2005).   
Implications for SCNT 
  The data presented in the three localization experiments has implications for the 
field of somatic cell nuclear transfer (SCNT).  Recently, Demecolcine has been used to 
chemically assist the enucleation of oocytes for the purposes of mammalian cloning in 
several species.  While this process has been shown to produce healthy cloned offspring 
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slightly more efficiently than conventional enucleation methods, the overall efficiency of 
such procedure remains low.  Since the majority of the data presented here indicate that 
Demecolcine could have a deleterious affect on the localization of the APC, it is 
conceivable that this could contribute to the low efficiency by reducing the 
developmental competence of the donor oocytes.  Therefore, it would be advantageous to 
develop a protocol that would continue to exploit the enucleation ability of Demecolcine 
to assist oocytes in the extrusion of DNA while simultaneously maintaining a high 
functional activity of the anaphase-promoting complex.   
In order to test the effectiveness of such a protocol, ubiquitin assays similar to 
those described by Rape et al. (2006) can be completed on lysates of oocytes enucleated 
by conventional methods and assisted by Demecolcine.  If the APC is shown to be more 
active in cells enucleated with Demecolcine, this could help to explain the higher 
efficiency of chemical assisted enucleation. 
  
Future Experiments 
 Because the data regarding the effects of Demecolcine (and other MT 
destabilizing drugs) on the APC are still in their infancy, more experiments that measure 
APC activity (both directly and indirectly) are required.  Firstly, a series of western blots 
should be designed to measure relative protein concentrations of Cdc20, Rec8, and 
several other APC substrates like securin and cyclin B at all stages of development.  
These blots could corroborate the evidence presented earlier that both Cdc20 and Rec8 
concentrations normally change significantly as the cell develops.  These concentration 
changes would be closely monitored in the presence and absence of Demecolcine to 
determine if the drug interferes with the orderly destruction of these and other protein 
substrates.  Since the timely destruction is a hallmark of APC function, these western 
blots would serve as an indirect measure of APC activity.   
 Following the Westerns, a sequence of rt-PCR and RNAi experiments could be 
developed to study gene expression of the anaphase promoting complex and other key 
cell cycle regulators.  Often with conventional SCNT methods, the gene expression of the 
reconstructed embryo differs from that of the parent organism.  This patterning can occur 
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even if the entire genome is identical.  While reasons for this phenomenon have since 
been attributed to the donor karyoplast, recent experimental observations have suggested 
that the recipient cytoplast is equally important in the reprogramming of the gene 
expression.  Thus, it would be invaluable to understand the gene expression of key cell 
cycle regulators like the Anaphase Promoting Complex following reconstruction into a 
cytoplast created by Demecolcine-assisted enucleation.   
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Appendix A:  Hela cell split protocol  
 
1. Aspirate media 
2. Rinse 3 times with PBS (-Ca2+-Mg2+) 
3. Aspirate PBS 
4. Add 1.5 ml typsin/EDTA  
5. When cells have detached from the culture dish, add 5 ml EMEM +FBS and 
pen/strep 
6. Centrifuge at 16,000 rpm for 5 min 
7. Aspirate media  
8. Resuspend in EMEM 
 
 
Appendix B: Chemical Components  
Media Composition 
 
FHM 
Base Catalog # MR-024 
Working pH range 7.2 - 7.4 
Components              mg/L 
CaCl2-2H2O 251.00 
KCL 186.00 
KH2PO4 47.60 
MgSO4 (anhyd.) 24.10 
MgSO4-7H2O --- 
NaCl 5550.00 
NaHCO3 336.00 
BSA 1000.00 
EDTA 3.80 
D-Glucose 36.00 
HEPES 4760.00 
Hyaluronidase (U/L) --- 
Calcium Lactate --- 
Sodium Lactate 60% (ml/L) 1.86 
Lactate NaSalt (ml/L) 1.42 --- 
Sodium Pyruvate 22.00 
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Phenol Red 10.00 
L-Glutamine 146.00 
Penicillin G Na Salt (u/L) 100,000.00 
Streptomycin Sulfate 50.00 
http://www.specialtymedia.com/05Resources/Formulations/mmformulation2.htm 
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KSOM  
Base Catalog # MR-106 MR-107 MR-121 
Working pH range 7.2 - 7.4 7.2 - 7.4 7.2 - 7.4 
Components mg/L mg/L mg/L 
Inorganic Salts             
CaCl2-2H2O 250.00 250.00 250.00 
KCL 186.38 186.38 186.38 
KH2PO4 47.99 47.99 47.99 
MgSO4 --- --- 0.00 
MgSO4 7H2O 49.30 49.30 49.30 
NaCl 5551.80 5551.80 5551.80 
NaHCO3 2100.25 2100.25 2100.25 
Other Components      
EDTA 3.72 3.72 3.72 
D-Glucose 36.03 36.03 36.03 
Sodium Lactate  1121.00 1121.00 --- 
Lactate NaSalt (ml/L) 
1.42 
--- --- 1121.00 
Sodium Pyruvate 22.00 22.00 22.00 
BSA 1000.00 --- 1000.00 
Phenol Red ---- --- 10.00 
Amino Acids                         
L-Arginine 63.20 63.20 63.20 
L-Cystine 12.02 12.02 12.02 
L-Cystine-2HCL --- --- 0.00 
L-Glutamine 146.15 146.15 146.15 
Glycine 3.75 3.75 3.75 
L-Histidine --- --- --- 
L-Histidine.HCl.H2O 20.96 20.96 20.96 
L-Isoleucine 26.23 26.23 26.23 
L-Leucine 26.24 26.24 26.24 
L-Lysine --- --- --- 
L-Lysine.HCl 36.52 36.52 36.52 
L-Methionine 7.46 7.46 7.46 
L-Phenylalanine 16.52 16.52 16.52 
L-Serine 5.26 5.26 5.26 
L-Threonine 23.82 23.82 23.82 
L-Tryptophan 5.11 5.11 5.11 
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L-Tyrosine 18.12 18.12 18.12 
L-Tyrosine NaH2O --- --- 0.00 
L-Valine 23.42 23.42 23.42 
L-Alanine 4.45 4.45 4.45 
L-Asparagine --- --- --- 
L-Asparagine-H2O 7.50 7.50 7.50 
L-Aspartic Acid 6.66 6.66 6.66 
L-Glutamic Acid 7.36 7.36 7.36 
L-Proline 5.76 5.76 5.76 
Antibiotics                          
Pen G Na Salt (units) 100,000.00 100,000.00 100,000.00 
Strep Sulfate 50.00 50.00 50.00 
http://www.specialtymedia.com/05Resources/Formulations/KSOM%20FormulationNew.htm 
 
 
MTSB-XF 
All chemicals purchased from Sigma Aldrich unless otherwise indicated.  
% given in v/v in Phosphate Buffered Saline 
PIPES 100mM 
MgCl2 5mM 
EGTA 2.5mM 
DTT 1mM 
Taxol 1uM 
Aprotinin 0.01% 
Deuterium 
oxide 50% 
Formaldehyde 3.70% 
Triton X-100 0.10% 
 
 
Blocking Buffer 
All chemicals purchased from Sigma Aldrich unless otherwise indicated. 
% given in w/v for solid and v/v for liquid chemicals in Phosphate Buffered Saline 
Sodium azide 0.20% 
Bovine Serum Abumin Fraction V 1%  
Powdered milk; Carnation 0.2%  
Normal Goat Serum (heat 
inactivated) 2%  
Glycine 0.1M 
Triton X-100 0.01% 
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Blocking Buffer (-goat serum) 
All chemicals purchased from Sigma Aldrich unless otherwise indicated. 
% given in w/v for solid and v/v for liquid chemicals in Phosphate Buffered Saline 
Sodium azide 0.20% 
Bovine Serum Abumin Fraction V 1%  
Powdered milk; Carnation 0.2%  
Glycine 0.1M 
Triton X-100 0.01% 
 
 
 
